Assessment of the lightcycler PCR assay for diagnosis of invasive aspergillosis in paediatric patients with onco-haematological diseases

Mycoses

Volumn 51, Issue 6, 2008, Pages 497-504

  Cesaro, S ^a   Stenghele, C ^a   Calore, E ^a   Franchin, E ^a   Cerbaro, I ^a   Cusinato, R ^a   Tridello, G ^a   Manganelli, R ^a   Carli, M ^a   Palu G ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Galactomannan antigen; Invasive aspergillosis; LightCycler PCR; Paediatric malignancy

Indexed keywords

FUNGAL DNA; GALACTOMANNAN;

ADOLESCENT; ADULT; ARTICLE; ASPERGILLOSIS; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CHILD; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HEMATOLOGIC DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STEM CELL TRANSPLANTATION;

ADOLESCENT; ASPERGILLOSIS; CHILD; CHILD, PRESCHOOL; DNA, FUNGAL; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; INFANT; MALE; MANNANS; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

NUCLEOPOLYHEDROVIRUS;

EID: 53549091318     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2008.01512.x     Document Type: Article

References (37)

1. Latge JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999 12 : 310 50.
2. Patterson TF, Kirkpatrick WR, White M et al. Invasive aspergillosis disease spectrum, treatment practices, and outcomes The Aspergillus Study Group. Medicine 2000 79 : 250 60.
3. Lin SJ, Schranz J, Teusch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001 32 : 358 66.
4. Marr KA, Carter RA, Boeckh M, Martin P, Corey L. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 2002 100 : 4358 66.
5. McNeil MM, Nash SL, Hajjeh RA et al. Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997. Clin Infect Dis 2001 33 : 641 7.
6. Thomas KE, Owens CM, Veys PA, Novelli V, Costoli V. The radiological spectrum of invasive aspergillosis in children: a 10-year review. Pediatr Radiol 2003 33 : 453 60.
7. Denning DW, Kibbler CC, Barnes RA. British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections. Lancet Infect Dis 2003 3 : 230 40.
8. Mennink-Kersten MASH, Donnelly JP, Verweij PE. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis 2004 4 : 349 57.
9. Quindos G. New microbiological techniques for the diagnosis of invasive mycoses caused by filamentous fungi. Clin Microbiol Infect 2006 12 (Suppl. 7 40 52.
10. Wheat LJ. Antigen detection, serology, and molecular diagnosis of invasive mycoses in the immunocompromised host. Transpl Infect Dis 2006 8 : 128 39.
11. Steinbach WJ. New findings and unique aspects in pediatric aspergillosis. Med Mycol 2005 43 (Suppl. 1 261 5.
12. Herbrecht R, Letscher-Bru V, Oprea C et al. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol 2002 20 : 1898 906.
13. White PL, Linton CJ, Perry MD, Johnson EM, Barnes RA. The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting. Clin Infect Dis 2006 42 : 479 86.
14. Donnelly JP. Polymerase chain reaction for diagnosing invasive aspergillosis: getting closer but still a way to go. Clin Infect Dis 2006 42 : 487 9.
15. Lewis White P, Barnes RA. Aspergillus PCR-platforms, strengths and weaknesses. Med Mycol 2006 44 : S191 8.
16. Loeffler J, Henke N, Hebart H et al. Quantification of fungal DNA by using fluorescence resonance energy transfer and the light cycler system. J Clin Microbiol 2000 38 : 586 90.
17. Spiess B, Buchheidt D, Baust C et al. Development of a LightCycler PCR assay for detection and quantification of Aspergillus fumigatus DNA in clinical samples from neutropenic patients. J Clin Microbiol 2003 41 : 1811 8.
18. Pryce TM, Kay ID, Palladino S, Heath CH. Real-time automated polymerase chain reaction (PCR) to detect Candida albicans and Aspergillus fumigatus DNA in whole-blood from high-risk patients. Diagn Microbiol Infect Dis 2003 47 : 487 96.
19. Caillot D, Casasnovas O, Bernard A et al. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 1997 15 : 139 47.
20. Maertens J, Theunissen K, Verbeken E et al. Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients. Br J Haematol 2004 124 : 852 60.
21. Hughes WT, Armstrong D, Bodey GP et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002 34 : 730 51.
22. Walsh TJ, Finberg RW, Arndt C et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute Institute of Allergy and Infectious Diseases Mycoses Study Group. N Engl J Med 1999 340 : 764 71.
23. Goodman JL, Winston DJ, Greenfield RA et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 1992 326 : 845 51.
24. Glasmacher A, Prentice A, Gorschlüter M et al. Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3597 patients. J Clin Oncol 2003 21 : 4615 26.
25. Ascioglu S, Rex JH, de Pauw B et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants : an international consensus. Clin Infect Dis 2002 34 : 7 14.
26. Denning DW, Ribaud P, Milpied N et al. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin Infect Dis 2002 34 : 563 71.
27. Maertens J, Verhaegen J, Lagrou K, Van Eldere J, Boogaerts M. Screening for circulating galactomannan as non invasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood 2001 97 : 1604 10.
28. Adam O, Auperin A, Wilquin F, Bourhis JH, Gachot B, Chachaty E. Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies. Clin Infect Dis 2004 38 : 917 20.
29. Buchheidt D, Hummel M, Schleiermacher D et al. Prospective clinical evaluation of LightCyclerTM-mediated polymerase chain reaction assay, a nested-PCR assay and a galactomannan enzyme-linked immunosorbent assay for detection of invasive aspergillosis in neutropenic cancer patients and haematological stem cell transplant recipients. Br J Haematol 2004 125 : 196 202.
30. Einsele H, Hebart H, Roller G et al. Detection and identification of fungal pathogens in blood by using molecular probes. J Clin Microbiol 1997 35 : 1353 60.
31. Marr KA, Balajee SA, McLaughlin L, Tabouret M, Bentsen C, Walsh TJ. Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. J Infect Dis 2004 190 : 641 9.
32. Lass-Flörl C, Gunsilius E, Gastl G et al. Diagnosing invasive aspergillosis during antifungal therapy by PCR analysis of blood samples. J Clin Microbiol 2004 42 : 4154 7.
33. Lass-Flörl C, Aigner J, Gunsilius E et al. Screening for Aspergillus spp. Using polymerase chain reaction of whole blood samples from patients with haematological malignancies. Br J Haematol 2001 113 : 180 4.
34. Lass-Flörl C, Salzer GM, Schmid T, Rabl W, Ulmer H, Dierichi MP. Pulmonary Aspergillus colonization in humans and its impact on management of critically ill patients. Br J Haematol 1999 104 : 745 7.
35. Young RC, Bennet JE, Vogel CL, Carbone PP, DeVita VT. Aspergillosis. The spectrum of the disease in 98 patients. Medicine 1970 49 : 147 73.
36. Groll AH, Shah PM, Mentzel C, Schneider M, Just-Nuebling G, Huebner K. Trends in post-mortem epidemiology of invasive fungal infections at a university hospital. J Infect 1996 33 : 23 32.
37. Maertens J, Theunissen K, Verhoef G et al. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study. Clin Infect Dis 2005 41 : 1242 50.